HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guido Coggi Selected Research

Philadelphia Chromosome

3/2011Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms.
12/2007VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guido Coggi Research Topics

Disease

11Neoplasms (Cancer)
03/2011 - 06/2002
4Carcinoma (Carcinomatosis)
09/2003 - 06/2002
3Lung Neoplasms (Lung Cancer)
05/2006 - 06/2002
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2006 - 06/2002
2Philadelphia Chromosome
03/2011 - 12/2007
2Hepatocellular Carcinoma (Hepatoma)
04/2009 - 10/2007
2Fibrosis (Cirrhosis)
10/2004 - 08/2002
1Adenocarcinoma
07/2013
1Primary Myelofibrosis (Myelosclerosis)
03/2011
1Mesothelioma
03/2009
1Breast Neoplasms (Breast Cancer)
04/2008
1Myeloproliferative Disorders (Myeloproliferative Disorder)
12/2007
1Liver Diseases (Liver Disease)
10/2007
1Liver Neoplasms (Liver Cancer)
10/2007
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2007
1Lymphangioleiomyomatosis (Lymphangiomyomatosis)
10/2005
1Tuberous Sclerosis (Bourneville's Disease)
10/2005
1Angiomyolipoma
10/2005
1Pleurisy (Pleuritis)
05/2005
1Malignant Mesothelioma
05/2005
1Viremia
10/2004
1Iron Overload
10/2004
1Leydig Cell Tumor
11/2003
1Atrophy
11/2003
1Adenomatoid Tumor
11/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2003
1Sarcoma (Soft Tissue Sarcoma)
07/2003
1Ovarian Neoplasms (Ovarian Cancer)
04/2003

Drug/Important Bio-Agent (IBA)

7Messenger RNA (mRNA)IBA
04/2009 - 04/2003
5Proteins (Proteins, Gene)FDA Link
03/2011 - 07/2003
5SurvivinIBA
04/2009 - 08/2003
2Biological ProductsIBA
07/2013 - 05/2006
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2011 - 12/2007
2Humanized Monoclonal AntibodiesIBA
09/2003 - 07/2003
2Telomerase (Telomerase Reverse Transcriptase)IBA
04/2003 - 06/2002
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
03/2011
1Pharmaceutical PreparationsIBA
05/2010
1Small Interfering RNA (siRNA)IBA
03/2009
1Formaldehyde (Formol)FDA Link
04/2008
1ParaffinIBA
04/2008
1Indicators and Reagents (Reagents)IBA
05/2006
1Keratin-8 (Keratin 8)IBA
10/2005
1Actins (F Actin)IBA
10/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2005
1trans-sodium crocetinate (crocetin)IBA
10/2005
1Epidermal Growth Factor (EGF)IBA
10/2005
1IronIBA
10/2004
1Ferritins (Ferritin)IBA
10/2004
1Transaminases (Aminotransferases)IBA
10/2004
1Inhibitor of Apoptosis ProteinsIBA
08/2003
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2003
1PlatinumIBA
04/2003
1Cyclin-Dependent Kinase Inhibitor p16IBA
08/2002
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
08/2002

Therapy/Procedure

4Therapeutics
04/2008 - 04/2003
2Drug Therapy (Chemotherapy)
05/2005 - 04/2003
1Conservative Treatment
11/2003
1Orchiectomy (Orchidectomy)
11/2003